Hormone Sensitive Metastatic Prostate Cancer: Clinical Trials

1 trial for Hormone Sensitive Metastatic Prostate Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Hormone Sensitive Metastatic Prostate Cancer: new trials by email Literature Review of Hormone Sensitive Metastatic Prostate Cancer trials Research Report on Hormone Sensitive Metastatic Prostate Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Efficacy and Safety of Docetaxel Combined With Platinum for Metastatic Hormone-sensitive Prostate Cancer
Docetaxel, Prednisolone Acetate, Platinum-based drugs - Hormone Sensitive Metastatic Prostate Cancer, DNA Damage Repair Deficiency
Phase 2UnknownThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School502022-07-012022-10-24

Interventions

Docetaxel (1)  ·  prednisolone acetate (1)

Sponsors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1)

Countries

China (1)

Top investigators

Hongqian Guo (1)